Catch up on the latest scientific research and cutting-edge Promega technologies.
Understanding the Complicated Relationship Between Insulin, Glucagon and GIP
A diabetic scientist provides new insights into how insulin and glucagon regulate energy metabolism.
Living Life to the Fullest: A Decade with Lynch Syndrome
Read the story of Mike Dampf, who found out he had Lynch syndrome when he was diagnosed with colon cancer at age 37.
MSI Testing in Diverse Populations
Understanding the limitations of MSI assays across racial populations may be essential for determining therapeutic options for racially and ethnically diverse patient populations.
Life with Lynch Syndrome
Carrie Ketcham had her first cancer diagnosis at age 44 and was diagnosed with Lynch syndrome five year later. Read her story.
Immunogenic Cell Death: Methods to Measure Damage Associated Molecular Patterns (DAMP)
Easily monitor immunogenic cell death with two homogeneous, bioluminescent assays.
Lumit™ Cytokine Assays: Interpolating Data with the GloMax® Discover
The GloMax® Discover enables rapid interpolation of unknown cytokine concentrations.
Homogeneous Assays for Triglyceride Metabolism Research
Measuring triglycerides and their metabolism is important for understanding metabolic disease.
Verifying Cell-Based Assays for Use with 3D Models
The use of 3D models provides increased physiological relevance, but it can also present challenges.
Considerations for PCR-Based Viral Assay Development
PCR-based testing is an important tool for detecting SARS-CoV-2 virus in samples.
In the News
Business Wire (June 2022): Renewable Sources Now Supplying Over 20% of Promega Global Electricity Use
Biocompare (May 2022): Designing 3D Cell-Based Assays
NBC15 (May 2022): Madison College students showcase robotic systems
Wisconsin State Journal (April 2022): Promega unveils post-doctoral program for scientists to research gene editing